Back
Also listed as
FMCQF
OTC
Day Range
$21.91
$22.14
52-Week Range
$20.95
$30.46
Volume
445,450
50D / 200D Avg
$23.04
/
$24.94
Prev Close
$21.90
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 13.0 | 0.4 |
| P/B | 0.9 | 2.9 |
| ROE % | 6.8 | 3.9 |
| Net Margin % | 5.0 | 3.8 |
| Rev Growth 5Y % | 2.7 | 10.0 |
| D/E | 0.8 | 0.2 |
Analyst Price Target
Hold
$28.00
+27.1%
Forward P/E
10.7
Forward EPS
$2.05
EPS Growth (est.)
+0.0%
Est. Revenue
20 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.24
$3.12 – $3.42
|
23 B | 1 |
| FY2029 |
$2.94
$2.83 – $3.10
|
22 B | 1 |
| FY2028 |
$2.51
$2.42 – $2.66
|
21 B | 2 |
Key Takeaways
Revenue grew 2.74% annually over 5 years — modest growth
Earnings grew 81.81% over the past year
Generating 1.70B in free cash flow
P/E of 12.98 — trading at a low valuation
PEG of 0.14 suggests growth is underpriced
Cash machine — converts 173.41% of earnings into free cash flow
Growth
Revenue Growth (5Y)
2.74%
Revenue (1Y)1.51%
Earnings (1Y)81.81%
FCF Growth (3Y)-6.60%
Quality
Return on Equity
6.78%
ROIC5.46%
Net Margin4.98%
Op. Margin9.31%
Safety
Debt / Equity
0.76
Current Ratio1.26
Interest Coverage0.00
Valuation
P/E Ratio
12.98
P/B Ratio0.89
EV/EBITDA11.98
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.51% | Revenue Growth (3Y) | 0.45% |
| Earnings Growth (1Y) | 81.81% | Earnings Growth (3Y) | 40.00% |
| Revenue Growth (5Y) | 2.74% | Earnings Growth (5Y) | 0.22% |
| Profitability | |||
| Revenue (TTM) | 19.63B | Net Income (TTM) | 978.00M |
| ROE | 6.78% | ROA | 3.15% |
| Gross Margin | 25.62% | Operating Margin | 9.31% |
| Net Margin | 4.98% | Free Cash Flow (TTM) | 1.70B |
| ROIC | 5.46% | FCF Growth (3Y) | -6.60% |
| Safety | |||
| Debt / Equity | 0.76 | Current Ratio | 1.26 |
| Interest Coverage | 0.00 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 12.98 | P/B Ratio | 0.89 |
| P/S Ratio | 0.65 | PEG Ratio | 0.14 |
| EV/EBITDA | 11.98 | Dividend Yield | 0.03% |
| Market Cap | 12.70B | Enterprise Value | 21.89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 19.63B | 19.34B | 19.45B | 19.40B | 17.62B |
| Net Income | 978.00M | 537.91M | 499.00M | 673.41M | 969.31M |
| EPS (Diluted) | 1.68 | 0.92 | 0.85 | 0.57 | 0.83 |
| Gross Profit | 5.03B | 4.76B | 4.93B | 4.89B | 4.77B |
| Operating Income | 1.83B | 1.39B | 1.37B | 1.51B | 1.85B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 31.00B | 33.57B | 33.93B | 35.75B | 34.37B |
| Total Liabilities | 16.72B | 17.80B | 19.10B | 20.30B | 20.39B |
| Shareholders' Equity | 14.28B | 14.58B | 13.62B | 13.99B | 12.70B |
| Total Debt | 10.80B | 11.00B | 12.08B | 13.21B | 13.32B |
| Cash & Equivalents | 1.60B | 1.18B | 1.40B | 1.27B | 1.48B |
| Current Assets | 7.90B | 7.92B | 8.70B | 8.20B | 7.97B |
| Current Liabilities | 6.25B | 5.66B | 6.11B | 6.47B | 7.26B |